The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-line (1L) datopotamab deruxtecan (Dato-DXd) + rilvegostomig in advanced or metastatic non-small cell lung cancer (a/mNSCLC): Results from TROPION-Lung04 (cohort 5).
 
Saiama Waqar
Consulting or Advisory Role - Amgen; AstraZeneca; Boehringer Ingelheim; Daiichi Sankyo; Gilead Sciences; Johnson & Johnson/Janssen; Pfizer
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Daiichi Sankyo (Inst); Elevation Oncology (Inst); Genentech (Inst); Janssen (Inst); Lilly (Inst); Nuvalent, Inc. (Inst); Ribon Therapeutics (Inst); Roche (Inst); Xcovery (Inst)
 
Kristof Cuppens
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca/MedImmune; Bristol-Myers Squibb; Daiichi Sankyo Europe GmbH; ITeos Therapeutics; Janssen; MSD; Pierre Fabre; Roche/Genentech
Expert Testimony - AstraZeneca; MSD
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo Europe GmbH; Janssen; MSD; Roche/Genentech
 
Rosario Campelo
Honoraria - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol Myers Squibb Foundation; Lilly; MSD; Novartis; Pfizer; Roche; Takeda
Consulting or Advisory Role - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol Myers Squibb Foundation; Lilly; MSD; Novartis; Pfizer; Roche; Takeda
 
Rafal Dziadziuszko
Honoraria - AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; MSD Oology; Pfizer; Roche/Genentech
Consulting or Advisory Role - GlaxoSmithKline
Travel, Accommodations, Expenses - AstraZeneca; GlaxoSmithKline; Pfizer
 
Enric Carcereny
Consulting or Advisory Role - AstraZeneca Spain; Boehringer Ingelheim; Bristol-Myers Squibb; MSD Oncology; Pfizer; Roche/Genentech; Takeda
Speakers' Bureau - AstraZeneca Spain; BMSi; MSD Oncology; Roche; Takeda
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Roche; Takeda
Other Relationship - MSD
 
Tsung-Ying Yang
Consulting or Advisory Role - AstraZeneca; Takeda
Travel, Accommodations, Expenses - AstraZeneca; MERCK
 
Jin-Yuan Shih
Honoraria - ABBVIE/ABBOTT; ACT Genomics; ACTgenomic; Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Chugai Pharma; CStone Pharmaceuticals; Daiichi-Sankyo; GlaxoSmithKline,; Guardant Health; Illumina; Janssen; Lilly; Lotus; Merck KGaA; Merck Sharp & Dohme; Novartis; Ono Pharmaceutical; Orient EuroPharma; Pfizer; Roche; Synmosa Biopharma; Takeda; TSH Biopharm; TTY Biopharm; Welgene Biotech; Zuellig Pharma
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Janssen Oncology; Merck Sharp & Dohme; Pfizer; Roche; Takeda; Zuellig Pharma
Research Funding - Roche
Travel, Accommodations, Expenses - AstraZeneca; Chugai Pharma; Pfizer; Roche
 
Giselle Dutcher
No Relationships to Disclose
 
Silvia Novello
Honoraria - Abbvie; AstraZeneca; BeiGene; BMS GmbH & Co. KG; Boehringer Ingelheim; Lilly; MSD; Pfizer; PharmaMar; Roche; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; AstraZeneca; Daiichi Sankyo Europe GmbH; GlaxoSmithKline; Lilly
Travel, Accommodations, Expenses - Sanofi
 
Izabela Chmielewska
Honoraria - Amgen; AstraZeneca; BMS; MSD
Travel, Accommodations, Expenses - MSD
 
Ewa Kalinka
Honoraria - AstraZeneca; Bristol-MYERS SQUIBB; Daiichi Sankyo/Astra Zeneca; Gilead Sciences; GlaxoSmithKline; Immutep; MSD; Nektar; Regeneron; Roche
Consulting or Advisory Role - Adamed; AstraZeneca; Bristol-Myers Squibb; Gilead Sciences; MSD Oncology
Speakers' Bureau - Bristol-Myers Squibb; Roche
Research Funding - AstraZeneca; Bristol-Myers Squibb; Merck Sharp & Dohme; Nektar; Roche
Travel, Accommodations, Expenses - Gilead Sciences; MSD; Roche
 
Mehmet Sendur
Honoraria - Amgen; Astellas Pharma; Bayer; Bristol-Myers Squibb; Janssen; MSD; Novartis; Pfizer; Roche; Takeda
Speakers' Bureau - Abdi Ibrahim; Abdi Ibrahim; Amgen; Astellas Pharma; Bristol-Myers Squibb; Janssen; Novartis; Pfizer; Roche; Takeda
 
Kazushige Wakuda
Honoraria - AstraZeneca; Boehringer Ingelheim; Chugai Pharma; Novartis; Ono Pharmaceutical; Taiho Pharmaceutical
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Daiichi Sankyo/UCB Japan (Inst); MSD (Inst)
 
Alexandra Tyulyandina
Employment - AstraZeneca
Honoraria - AstraZeneca/MedImmune; BioCad; Eisai; Merck; MSD Oncology; Novartis; R-Pharm; Roche
Consulting or Advisory Role - AstraZeneca/MedImmune; Eisai; MSD Oncology
Research Funding - AstraZeneca/MedImmune; biocad; MSD Oncology
 
Mateusz Hinzmann
Employment - AstraZeneca
 
Xiaojin Shi
No Relationships to Disclose
 
Shankar Bodla
Employment - AstraZeneca
 
Kyriakos Papadopoulos
Consulting or Advisory Role - AADi; Turning Point Therapeutics
Research Funding - 3D Medicines (Inst); Abbvie (Inst); Alnylam (Inst); Amgen (Inst); Anheart Therapeutics (Inst); AstraZeneca (Inst); Bayer (Inst); Bicycle Therapeutics (Inst); Biontech (Inst); Bristol-Myers Squibb/Celgene (Inst); CytomX Therapeutics (Inst); Daiichi Sankyo (Inst); Debiopharm Group (Inst); F-star (Inst); Frontier Medicines (Inst); Genmab (Inst); Incyte (Inst); Jounce Therapeutics (Inst); Kezar Life Sciences (Inst); Lilly (Inst); Linnaeus Therapeutics (Inst); MabSpace Biosciences (Inst); Merck (Inst); Mersana (Inst); Mirati Therapeutics (Inst); Monte Rosa Therapeutics (Inst); Parabilis Medicines (Inst); Pfizer (Inst); PharmaMar (Inst); Regeneron (Inst); Revolution Medicines (Inst); Sensei Biotherapeutics (Inst); Storm Therapeutics (Inst); Syros Pharmaceuticals (Inst); Tempest Therapeutics (Inst); Treadwell Therapeutics (Inst)